1. Pazopanib in Patients with Osteosarcoma Metastatic to the Lung: Phase 2 Study Results and the Lessons for Tumor Measurement. (15th January 2022) Authors: Frankel, Paul; Ruel, Chris; Uche, An; Choy, Edwin; Okuno, Scott; Somiah, Neeta; Chow, Warren A. Other Names: Miwa Shinji Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies. Issue 2 (28th January 2020) Authors: Siddiqi, Tanya; Frankel, Paul; Beumer, Jan H.; Kiesel, Brian F.; Christner, Susan; Ruel, Chris; Song, Joo Y.; Chen, Robert; Kelly, Kevin R.; Ailawadhi, Sikander; Kaesberg, Paul; Popplewell, Leslie; Puverel, Sandrine; Piekarz, Richard; Forman, Stephen J.; Newman, Edward M. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 2(2020) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma. Issue 1 (11th September 2019) Authors: Chow, Warren; Frankel, Paul; Ruel, Chris; Araujo, Dejka M.; Milhem, Mohammed; Okuno, Scott; Hartner, Lee; Undevia, Samir; Staddon, Arthur Journal: Cancer Issue: Volume 126:Issue 1(2020) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗